Introduction
Ischaemia, subsequent to artery obstruction in peripheral tissues, heart and brain, is responsible for half of the deaths in Europe and North America. Although recent progress in medical treatments has led to increased survival and quality of life for patients, results remain inconsistent especially in aged and diabetic patients. The concept that new blood vessels can be grown to enhance tissue perfusion is now achieving widespread acceptance. 1 To date several pro-angiogenic factors, including vascular endothelial growth factor (VEGF) and fibroblast growth factors (FGFs), have been tested in human clinical trials as a complement or an alternative to surgical re-vascularization; however, their effects remain limited. 2 Therefore, a better understanding of the underlying mechanisms involved in ischaemic muscle re-vascularization may help to optimize future clinical interventions. Embryonic signalling pathways, including the Hedgehog (Hh) pathway, provide promising new targets for angiogenic therapies. 3, 4 Indeed, previous investigations have reported that inhibition of Hh protein activity, by neutralizing 5E1 anti-body administration, impairs ischaemia-induced angiogenesis both in the setting of hind limb ischaemia (HLI), and myocardial infarction, in mice. 5, 6 Conversely, when Sonic Hedgehog (Shh), one of the Hh ligands, was administered either as a re-combinant protein or via gene therapy, it promoted neovascularization of ischaemic tissues by promoting both angiogenesis 7 and endothelial progenitor cell recruitment. 8 Studies conducted to elucidate cellular mechanisms responsible for these findings have shown that Shh induces over-expression of several proangiogenic growth factors, including VEGFA and Angiopoietin-1, by fibroblasts and cardiomyocytes. 7, 8 However, despite evidence for the in vivo effects of Hh signalling in adults, the molecular mechanisms by which endogenous Hh signalling contributes to ischaemia-induced angiogenesis have yet to be fully elucidated. For instance, since the 5E1 anti-body blocks activity of all three Hh ligands [Shh, Desert Hh (Dhh) and Indian Hh (Ihh)] 9 the specific role of each Hh protein in the regulation of blood vessel homeostasis has not yet been established. We recently demonstrated that Dhh is necessary to drive angiogenesis in ischaemic skeletal muscle. Interestingly, investigation of its mechanism of action revealed that it does not modulate endothelial cell (EC) function directly; on the contrary, it promotes angiogenesis by maintaining peripheral nerve-derived angiogenic factors in the ischaemic muscle. 10 The purpose of the present study was to investigate the specific role of endogenous Shh in ischaemia-induced angiogenesis. Among the three Hh ligands, Shh expression has previously been demonstrated to be the most up-regulated in the setting of ischaemia 7, 8, 10 ; with previous reports indicating that Shh is upregulated up to 80-fold in ischaemic skeletal muscle, 2 days after HLI is induced. 10 
Methods

Mice
Shh Floxed (Shh Flox ) mice, 11 Smo Floxed (Smo Flox ) mice, 12 Rosa26 mTmG mice, 13 HSA-Cre ERT2 mice, 14 and LysM-Cre mice 15 were obtained from Jackson Laboratories. Rosa26-Cre ERT2 mice 16 were obtained from the 'Institut Clinique de la Souris' (Strasbourg, France). Pdgfb-Cre ERT2 mice 17 were kindly provided by M. Fruttiger. Animal experiments were performed to conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes, and approved by the local Animal Care and Use Committee of Bordeaux University (CEEA50).
Rosa26-Cre
ERT2
, HSA-Cre
, and LysM-Cre mice were genotyped using the following primers 5'-TAAAGATATCTCACGTACTGACGG TG-3' and 5'-TCTCTGACCAGAGTCATCCTTAGC-3' that amplify 493 bp of the Cre re-combinase sequence. Pdgfb-Cre ERT2 mice were genotyped using the following primers 5'-CCAGCCGCCGTCGC AACT-3' and 5'-GCCGCCGGGATCACTCTCG-3'. Shh Floxed mice were genotyped using the following primers 5'-ATGCTGGCTCGC CTGGCTGTGGAA-5' and 5'-GAAGAGATCAAGGCAAGCTCTGG C-3', Smo Floxed mice were genotyped using the following primers 5'-CCACTGCGAGCCTTTGCGCTAC-3' and 5'-CCCATCACCTCCGC GTCGCA-3' which amplifies a 446 bp fragment of the WT allele and 5'-CTTGGGTGGAGAGGCTATTC-3' and 5'-AGGTGAGATGACAGGA GATC-3' which amplifies 280 bp of the floxed allele. Rosa26 mTmG mice were genotyped using the three following primers 5'-CTCTGCTGCCT CCTGGCTTCT-3', 5'-CGAGGCGGATCACAAGCAATA-3', and 5'-TCAATGGGCGGGGGTCGTT-3.' Cre re-combinase, of Rosa26-Cre ERT2 and Pdgfb-Cre ERT2 mice, was activated by intraperitoneal injection of 1 mg tamoxifen for five consecutive days starting 1 week before HLI surgery was performed. (i.e.: from day -7 to day -3 before surgery). Cre re-combinase of HSA-Cre ERT2 mice was activated by intraperitoneal injection of 1 mg tamoxifen for 10 consecutive days starting the day HLI surgery was performed (i.e.: from day 0).
HLI model and assessments
HLI was induced by ligation and re-section of the left femoral artery, as previously described. 10, 18 Briefly, mice were anesthetized with isoflurane, aseptically prepared and a 5 mm incision was made in the left thigh region. Two ligations were made around the femoral artery, at the proximal end of the femoral artery and the distal portion of the saphenous vein. The femoral artery and all side-branches were then dissected and excised. The connective tissues were closed with interrupted 6-0 absorbable sutures. To minimize pain caused by the surgery, mice were administered intraperitoneally with 0.05 mg/kg buprenorphin 30 min before and 8 h after surgery.
Mice were sacrificed by cervical dislocation at the indicated time points.
For histological assessment and gene expression analysis, tibialis anterior muscle was harvested, and cut in half. The lower half was fixed in methanol, paraffin-embedded, and cut into 6-mm sections, and the upper half was snap frozen in liquid nitrogen.
Foot perfusion was measured using a MoorLDI2-IR apparatus after mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg), and reported as the ratio of blood perfusion in the ischaemic vs. non-ischaemic limb.
Micro-CT vasculature imaging was performed as previously described. 19 More precisely, mice euthanized by a lethal injection of pentobarbital, were perfused via the ventral aorta first with a heparinized isotonic solution and then with a 10% Formalin solution, followed by a mixture of 88% Neoprene latex (Neoprene Latex Dispersion 671 A, Dupont, France) and barium sulphate (0.08 g/mL, MicrOpaque V R oral solution, Guerbet, France). Next, the mouse was put into acid solution for the latex to harden, then, after dissection; the organs were fixed overnight in 10% Formalin at 4 C. For mCT scanner data processing and analysis, we used the Skyscan1174 Micro-CT scanner from Bruker with spatial resolution of 6 to 30 lm, with the Skyscan V R and NRecon V R programs. Voltage parameters were 48 kV with a mean current of 805 lA. Our acquisition protocol consisted of 360 views with 5 averaged images per position, with a voxel volume of 17 lm 3 . 3 D images were obtained using the IMARIS V R program.
Immunostaining and quantifications
ECs were identified with rat anti-CD31 anti-bodies (BD Pharmingen Inc). Myocytes were identified using rabbit polyclonal anti-Desmin anti-bodies (Millipore), leucocytes were identified using rat anti-CD45 anti-bodies (BD Pharmingen Inc), neutrophils were identified using rat anti-Ly6G (GR1) anti-bodies (BD Pharmingen Inc), and macrophages were identified using rat anti-CD68 anti-bodies (Biolegend). VEGFA was stained using rabbit anti-VEGFA anti-bodies (Abcam). GFP was identified using rabbit anti-GFP anti-bodies (Molecular probe). For immunofluorescence analyses, primary anti-bodies were resolved with Alexa-Fluor-conjugated secondary anti-bodies (Invitrogen) and nuclei were counterstained with DAPI (1/5000). For immunohistochemical analyses, primary anti-bodies were sequentially stained with biotin-conjugated secondary anti-bodies (Vector Laboratories) and streptavidin-HRP complex (Amersham), then the stain was developed with a DAB substrate kit (Vector Laboratories); tissues were counterstained with haematoxylin. Capillary, neutrophil and macrophage density was evaluated in sections stained for the expression of CD31, GR1, and CD68, respectively. (per mouse) because we verified muscle repair is relatively uniform along the length of the tibialis anterior muscle. Myogenesis was assessed after Desmin staining of muscle sections as the percentage of Desminþ area. Only mice, in which there was histologic evidence of ischaemia in the tibialis anterior muscle, as assessed by haematoxylin and eosin (H&E) staining, were included in the study.
Plasmids/gene therapy
Gene therapy was performed in 12 week old mice. Immediately after HLI surgery was performed, mice were randomly assigned to receive 200 mg pIRES-EGFP or 200 mg pIRES-NShh 10 together with 0.05% pluronic. The DNA/pluronic mix was injected intramuscularly in the tibialis anterior muscle as previously described. 10 Mice scheduled to be sacrificed at day 5 were injected immediately after surgery while mice scheduled to be sacrificed at day 10 were injected both at day 0, immediately after surgery, and at day 4.
Flow cytometry
The ischaemic tibialis anterior muscle was subsequently dissociated in 2 mg/mL type 4 collagenase (Wortgingthon) for 1 h at 37 C and filtered on a 40 mm strainer. Macrophages were labelled with PE-conjugated anti-CD11b (Biolegend) and FITC-conjugated anti-CD11c (Biolegend) anti-body, before they were counted using a ACCURI V R C6 flow cytometer (BD). Neutrophils were labelled with APC conjugated anti-Ly6G and Ly6C (BD Pharmingen Inc).
Quantitative RT-PCR
RNA was isolated using Tri Reagent Table S1 .
The relative expression of each mRNA was calculated by the comparative threshold cycle method and normalized to HPRT mRNA expression.
Cell culture
Both C2C12 cells (ATCC) and RAW 264.7 macrophages (ATCC) were cultured in DMEM containing 4.5 g/L glucose and supplemented with 10% foetal bovine serum. Before any treatment, cells were serum starved in 0.5% foetal bovine serum containing culture medium for 24 h.
Primary cultured myoblasts were isolated from Smo Flox/Flox mice or their WT littermates as previously described. 20 Briefly, to isolate myoblasts, mouse limb skeletal muscle was dissociated in 2.4 U/mL dispase (Sigma) and 1.5 mg/mL collagenase 2 (Worthington) containing culture medium for 20 min at 37 C. Muscle cells were then seeded on 50 mg/mL type I collagen coated dishes (Sigma) and cultured in 20% FBS containing HAM F10 nutrient mixture. Round shape cells (i.e. myoblasts) were enriched, and fibroblasts were eliminated by passaging cells with PBS that contained no trypsin. To preserve a proliferating phenotype, myoblasts were maintained in culture medium containing 50% HAM F10 nutrient mixture and 50% DMEM, supplemented with 20% FBS and, FGF2 (2.5 ng/mL). Both Smo Flox/Flox and WT myoblasts were transduced with Cre-expressing lentiviruses 20 at a MOI of 20.
Migration assay
Cell migration was evaluated by using a modified Boyden's chamber (Neuro Probe, Inc). Briefly, a polycarbonate filter (8-mm pore size) (GE Infrastructure) was coated with a solution containing 0.1% gelatin (Sigma-Aldrich) and inserted between the upper and lower wells. Cells, 5 Â 10 4 per well, were seeded in the upper chamber, and the lower chamber contained myoblast-conditioned medium containing 2 mg/mL Ccl2 blocking anti-bodies (R&D systems) or isotype control. Migration was evaluated as the mean number of migrated cells in three high-power fields (HPF) (20Â magnification) per well. 
Phagocytosis assay
Statistics
Results are reported as mean ± SEM. Comparisons between groups were analysed for significance with the non-parametric Mann-Whitney test or with a one way ANOVA analysis followed by a Bonferroni's multiple comparison test when there were three or more groups to compare. Differences between groups were considered significant when P < 0.05. *: P < 0.05; **: P < 0.01; ***: P < 0.001.
Results
Endogenous Shh does not promote ischaemia-induced angiogenesis
To investigate the role of endogenous Shh in ischaemia-induced angiogenesis, we created Shh inducible knock out (iKO) adult mice. To this aim, we bred Shh conditional KO mice (Shh Flox ) with mice expressing the tamoxifen-inducible Cre ubiquitously (Rosa26-Cre ERT2 mice). We first assessed Cre re-combinase activity in the skeletal muscle of adult mice, by breeding Rosa26-Cre ERT2 mice with Rosa26 mTmG mice. Recombination of the Rosa26 mTmG allele was verified after GFP staining of skeletal muscle sections ( Figure 1A ). Additionally, effective Shh knockdown was verified by measuring Shh mRNA expression in the ischaemic and non-ischaemic skeletal muscle of Rosa26-Cre
ERT2
; Shh Flox/Flox mice.
As shown in Figure 1B , Shh mRNA expression was reduced by approximately 85% while Dhh and Ihh mRNA expression was not modulated
; Shh Flox/Flox (Shh iKO) and control Shh Flox/Flox mice then underwent HLI surgery. Re-vascularization of the ischaemic leg was evaluated, 5 and 10 days after surgery, by measuring capillary density in the ischaemic tibialis anterior muscle and foot perfusion. Unexpectedly, we found that capillary density was significantly increased in Shh deficient mice compared to control mice 5 days after HLI surgery was performed ( Figure 1E-F) . However, 10 days after surgery, capillary density was equivalent in both groups. Similarly, foot perfusion increased in Shh
Endogenous Shh limits angiogenesis deficient mice compared to control mice 5 days after HLI surgery. Foot perfusion was equivalent in both groups at day 10 post-surgery, consistent with capillary density data ( Figure 1G-H) .
Altogether these results demonstrate that Shh deficiency leads to a transiently increased angiogenesis in the ischaemic skeletal muscle however; this response appears to be inefficient and does not lead to a longlasting improved foot perfusion. Because this result was unexpected and contrary to previous reports, we administered Shh ectopically via gene therapy (Figure 2A-B) , in both Shh deficient mice and their control littermates, to confirm that we were able to reproduce results from the literature. 6, 7 As shown Figure 2C and D, Shh gene therapy significantly increased capillary density in control mice both at day 5 and at day 10, which is fully consistent with previous studies 7, 8, 21 and confirms that, when administered ectopically, Shh is pro-angiogenic. Blood flow was significantly increased at day 5, nevertheless, this effect was no longer observable at day 10 ( Figure 2E-F) . Notably, capillary density was increased by two-fold at day 5 while it was only increased by 1.5-fold at day 10. However, Shh gene therapy had no effect in Shh deficient mice in which capillary density was already high. In summary, ectopic administration of Shh did not rescue the phenotype of Shh deficient mice, suggesting that endogenous and exogenous Shh have different effects. Therefore, our data demonstrates that in contrast to Dhh, 10 endogenous Shh does not promote ischaemia-induced angiogenesis, and more likely attenuates the angiogenesis process. 
Endogenous Shh is necessary for new capillary muscularization but not arteriogenesis
Shh has been shown to be involved in blood vessel muscularization, 22 as such, we measured smooth muscle cell coverage of newly formed capillaries within the ischaemic muscle of Shh deficient mice and control mice. We found that the percentage of smooth muscle myosin heavy chain (smMHC) positive capillaries was significantly decreased in the absence of Shh, both 5 and 10 days after HLI was induced ( Figure 3A-B) , demonstrating that in the absence of Shh, angiogenesis is transiently increased but the newly formed capillaries remain immature. This latter result is consistent with previous literature reports, 7, 21, 22 and further confirms the essential role of Shh in blood vessel maturation. In addition, we evaluated the role of Shh in arteriogenesis using micro CT imaging. To do so, Shh iKO mice and their control littermates underwent HLI surgery. Five days later, mice were sacrificed and perfused with a barium/Latex mixture through the aorta. As shown in Figure 3C -E, collateral formation (i.e. collateral number and collateral diameter) were equivalent in Shh deficient and control mice, showing that endogenous Shh does not participate in collateral formation in the setting of ischaemia.
Endogenous Shh is not necessary for ischaemia-induced myogenesis
As Hh signalling is also known to participate in adult myogenesis, 23 we evaluated myogenesis in Shh deficient mice and their control littermates. Ten days after HLI surgery, the surface area of ischaemic muscle recolonized by new muscle fibers (desmin þ with central nuclei) was the same in Shh iKO mice and in control mice (see Supplementary material online, Figure S1A -B). Moreover, the expression profile of MyoD, an early marker of myogenesis (see Supplementary material online, Figure S1C) , and Myh1, a late marker of myogenesis, (see Supplementary material online, Figure S1D) were not different in the absence of Shh, demonstrating that Shh is not necessary for ischaemia-induced myogenesis. 
Endogenous Shh limits angiogenesis
Shh limits macrophage recruitment in the ischaemic muscle
As Shh is strongly over expressed 2 days after HLI surgery, and its expression is back to baseline at day 5, 10 we tested the role of Shh in early events, such as inflammation, following ischaemic injury.
To evaluate the impact of Shh KO on ischaemic muscle inflammation, both Shh iKO mice and their control littermates underwent HLI surgery, and neutrophil infiltration was evaluated 2 days later. As shown in Figure  4A and B, GR1þ neutrophil infiltration was not different in the presence or absence of Shh. This result was confirmed by FACS analysis of Ly6G, Ly6C positive cells ( Figure 4C) . In contrast, when we assessed macrophage infiltration, which typically peaks 5 days after ischaemia is induced, we found that CD68þ macrophage density in the ischaemic muscle was significantly increased in Shh deficient mice ( Figure 4D-E) , demonstrating that Shh limits macrophage recruitment. Similarly, the number of CD11b, CD11c double positive cells within the ischaemic muscle was significantly increased in Shh-deficient mice ( Figure 4F) .
Taken together these data demonstrate that Shh exhibits an antiinflammatory action in ischaemic tissue by limiting macrophage recruitment.
Shh does not limit macrophage recruitment by targeting macrophages directly
To better understand how Shh limits macrophage infiltration in the ischaemic muscle, we investigated the Shh-target cell type responsible for this effect. To do so, we used Smoothened conditional KO mice (Smo Figure S3C ) were equivalent in LysM-Cre, Smo Flox/Flox mice and their control littermates, demonstrating that Shh does not limit macrophage recruitment by signalling to macrophages directly. To further confirm this result, we performed in vitro assays using cultured macrophages. We first found that Shh recombinant protein had no effect on Gli1 or Gli2 mRNA expression (see Supplementary material online, Figure S4A-B) . Nevertheless, macrophages were sensitive to some autocrine-induced Hh signalling through Gli2 (see Supplementary material online, Figure S4B ), since inhibition of Smo with GCD-0449 significantly decreased Gli2 mRNA expression. Consistent with in vivo data, neither Shh treatment nor Smo inhibition modulated chemokine expression, including Ccl2 or Ccl5 (see Supplementary material online, Figure  S4C-D) , or macrophage migration (see Supplementary material online, Figure S4E ). In addition, Hh signalling had no effect on macrophage phagocytic activity (see Supplementary material online, Figure S4F ). Finally, we tested whether Shh or GDC-0449 would modulate VEGFA expression, and found they did not (see Supplementary material online, Figure S4G ). Accordingly, capillary density was not increased in LysM-Cre; Smo Figure S5A-B) . Nevertheless, we observed a significant decrease in capillary density at day 5 in LysM-Cre; Smo Flox/Flox mice which were associated with improved muscle perfusion 10 days after HLI surgery was performed (see Supplementary material online, Figure  S5C -D). This phenotype is more likely independent of Shh, since it is not re-capitulated in Shh deficient mice.
Shh does not limit macrophage recruitment by modulating EC phenotype
We next tested whether Shh limits macrophage density in ischaemic muscle by modulating the EC phenotype. EC are active players of macrophage recruitment through the expression of adhesion molecules for inflammatory cells. Smo deletion in ECs was achieved using PdgfbCre ERT2 mice, as previously described. 10 Macrophage infiltration was evaluated in the ischaemic muscle in Pdgfb-Cre
ERT2
; Smo Flox/Flox and control mice 5 days after HLI surgery, and Smo depletion in ECs did not lead to significant changes in macrophage density within the ischaemic muscle (see Supplementary material online, Figure S6A -B). Consistent with this, flow cytometry data showed that the number of CD11b, CD11c double positive cells was equivalent in both genotypes (see Supplementary material online, Figure S4C ). This result demonstrates that Shh does not limit macrophage recruitment by modulating the EC phenotype. Notably, we previously reported that neither capillary density nor blood flow recovery were modified in Pdgfb-cre Figure 5A-B) . This result was confirmed by flow cytometry analysis of CD11b, CD11c double positive cells ( Figure 5C ).
Together these results demonstrate that Shh does not limit macrophage recruitment in skeletal muscle by modulating inflammatory To further understand how Shh limits macrophage recruitment, we performed in vitro experiments using the C2C12 myoblast cell line. We found that inhibition of Hh signalling, with the Smo inhibitor GDC-0449, significantly increased expression of several cytokines that are chemotactic for macrophages, including Ccl2 and Ccl5 (Figure 5D-E) . We confirmed these results in primary cultured myoblasts isolated from To test whether Ccl2 produced by myoblasts can promote macrophage migration, we used conditioned medium from control and Smo KO myoblasts in which Ccl2 had or had not been blocked with anti-Ccl2 anti-bodies. We found that macrophage migration was significantly increased by Smo KO myoblast conditioned medium compared to control myoblast conditioned medium, and that Ccl2 blockage inhibited Smo KO myoblast-conditioned medium induced macrophage migration ( Figure 5I ).
These results demonstrate for the first time that endogenous Shh limits macrophage recruitment in ischaemic tissue by down-regulating chemokine expression in muscle cells.
'Hyperinflammation' induces a transient increase in angiogenesis in Hh deficient mice
Because macrophages are known to produce proangiogenic molecules including VEGFA, we evaluated angiogenesis in HSA-Cre Figure 6A-B) , which resulted in a significant increase in foot perfusion 10 days after HLI ( Figure 6C-D) . The increased capillary density was associated with significantly increased VEGFA levels ( Figure 6E-F) within the ischaemic muscle.
Discussion
To our knowledge, the present study is the first to use specific tools (i.e. Shh deficient mice) to investigate the role of endogenous Shh in angiogenesis in adult mice. This study demonstrates that endogenous Shh does not promote ischaemia-induced angiogenesis, on the contrary it reveals that angiogenesis is transiently increased in the absence of Shh (Figure 7) . This result was unexpected based on previous literature which demonstrated that administration of exogenous Shh promoted ischaemia-induced angiogenesis both in ischaemic skeletal muscle and infarcted heart muscle. 7, 8 Studies conducted to date have investigated the role of endogenous Hh signalling in ischaemic tissue repair, using non-specific tools such as the monoclonal anti-body 5E1 which blocks activity of the three different Hh ligands (Shh, Ihh, and Dhh) 6 or the Smo inhibitor Cyclopamine. 24 Moreover, the results of these studies were inconsistent; since Pola et al.
reported that Hh signalling blockage with 5E1 anti-bodies inhibited ischaemia-induced angiogenesis, while Bijlsma et al. reported that Hh signalling blockage with cyclopamine did not affect angiogenesis. Notably, our results are consistent with embryonic studies. Indeed, while ectopic Shh over-expression in the roof plate of the spinal cord was shown to induce hypervascularization of neurectoderm, 25 Chiang et al. did not observe any obvious vascular defects in Shh deficient embryos. 26 Consistent with this, Van Tuil et al. reported that the pulmonary vascular bed of Shh KO embryos was decreased, but appropriate to the decrease in airway branching. 27 In contrast, other Hh family members including Ihh, were shown to be necessary for the formation of the anterior aorta 28 and angiogenesis, especially in the yolk sac. 29 Additionally, this study reveals that Shh exerts an anti-inflammatory action in ischaemic tissue. The role of Shh as a regulator of inflammation was first suggested through its role in the regulation of thymocyte differentiation. 30, 31 Nevertheless, the role of Hh signalling in the regulation of inflammation is still poorly understood, while in vitro studies suggest that Shh promotes the expression of several chemokines including Ccl2, Ccl20, Cxcl1, Cxcl2, and Cxcl16 32, 33 ; studies performed in mice with impaired Hh signalling, have demonstrated that the loss of Hh signalling may lead to chronic tissue inflammation in the brain or intestine, [34] [35] [36] or limit inflammation in Helicobacter Pylori infected stomach. 37 Additionally, several pieces of evidence suggest that Hh signalling promotes Th2 differentiation of lymphocytes through the regulation of Il4, 38 or M2 differentiation of macrophages through regulation of Il10. 39 Our results are consistent with an anti-inflammatory role of Shh. We found for the first time that impaired Hh signalling in myoblasts promotes the expression of several Ccl chemokines. Our data confirms the role of Hh signalling as an essential regulator of tissue inflammation, and further demonstrates that Shh does not limit macrophage recruitment by signalling to macrophages directly or to ECs; but rather through the modulation of chemokine expression by myocytes ( Figure 7) . In addition to providing evidence for the role of Shh in tissue homeostasis and regeneration in adults, this study further elucidates the process of regulation in ischaemia-induced angiogenesis. Specifically, our data demonstrate that while increased macrophage recruitment in ischaemic muscle accelerates angiogenesis; this increased angiogenesis is transient and does not lead to a long-term increase in tissue perfusion. Consistent with these results, a recent study demonstrated that administration of CD14þ macrophages in mice increases the number of perfused blood vessels both in an in vivo Matrigel plug assay and in the HLI model in mice; however, the blood vessels formed in the CD14þ macrophage-treated mice remained large, leaky and unable to recruit pericytes. As a consequence, CD14þ macrophages induced pathologic rather than physiologic and persistent angiogenesis, which did not result in any improvement of limb perfusion 2 weeks after HLI was induced. 40 Although the study by Choi YE et al. used cultured human peripheral blood derived macrophages in immuno-deficient mice; our study confirms these results under 'fully physiological' conditions. Notably the vascular phenotype, we observed in the ischaemic muscle of Shh deficient mice which is associated with an increased macrophage-derived VEGFA, resembles that of tumour vasculature with a high density of poorly muscularized blood vessels that are inefficient at promoting tissue perfusion. 41 Accordingly, remodelling of the newly formed capillary network within the lower limb muscle has been recently suggested to be essential for efficient limb perfusion. Indeed, while capillary density within the ischaemic lower limb muscle (tibialis anterior and extensor digitorum longus muscle) is at least as high as that of a healthy muscle 10-14 days after HLI surgery, 10,42 limb perfusion remains low: the ratio of blood flow within the ischaemic muscle vs. healthy muscle remains only 0.5).
One of the proposed explanations for that is that the newly generated capillary network is poorly muscularized. 42 Although phenotyping LysM-Cre; Smo Flox/Flox mice, we found that Hh signalling is active in macrophages. Macrophages are sensitive to autocrine production of Ihh or Dhh, but not Shh. Nevertheless, Hh ligands do not modulate phagocytosis or macrophage migration. Notably, monocyte/macrophages were previously shown to produce Ihh and Dhh, 43 and macrophage derived-Ihh was shown to promote M2 differentiation of macrophages. 43 Moreover, we have shown that impaired Hh signalling in macrophages slows down angiogenesis and promotes capillary muscularization (data not shown). As discussed in the above paragraph, capillary muscularization which is a feature of newly formed capillary maturation is essential for their functionality and thus may be responsible for the significantly enhanced muscle perfusion observed in LysM-Cre; Smo Flox/Flox mice. However, the role of Hh signalling in macrophages in the setting of ischaemia-induced angiogenesis needs to be further investigated. Of note, Shh is not likely the Hh ligand controlling macrophages behaviour. Indeed, while impaired Hh signalling in macrophages promote capillary muscularization, Shh deficiency decreases capillary muscularization. Notably, we have previously reported that Shh of which expression is induced by PDGF-BB in SMCs, promotes capillary muscularization. 22 This previous report also explains why the percentage of smMHC positive vessel is significantly decreased in Shh iKO mice while it is not different from control mice, in HSA-Cre Finally, the present study reveals that endogenous Shh and ectopically administered N terminal-Shh act differently in the setting of ischaemic skeletal muscle repair. One explanation for this might be that the bioavailability (i.e. expression profile and solubility) of the two sources of Shh are different, however, further investigations are necessary to fully understand why exogenous N-terminal-Shh is pro-angiogenic while endogenous Shh is not. What is known so far is that when administered ectopically, Shh promotes VEGFA expression in fibroblasts and subsequently angiogenesis, what we found in the present study is that impaired Shh signalling in myocytes promotes the recruitment of VEGFAexpressing macrophages leading to an overall increased VEGFA expression within the ischaemic muscle. It should be noted that this is not the first study to report contradictory effects of Hh signalling on blood vessel biology, in the brain endogenous Hh signalling has been reported to promote blood brain barrier integrity, 34 while a recent study showed that brain tumour-derived Dhh contributed to enhanced vascular permeability. 44 
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